Wiener Klinische Wochenschrift

, Volume 116, Issue 9–10, pp 296–304 | Cite as

Behandlung der Achalasie

  • Enrico P. Cosentini
  • Etienne Wenzl
  • Raimund Jakesz
Übersicht
Received:
Accepted:

Zusammenfassung

Die Achalasie ist eine Motilitätsstörung der Speiseröhre unklarer Ätiologie. Sie ist durch eine fehlende oder nur geringe Relaxation des gastroösophagealen Sphinkters während des Schluckaktes und durch zumindest zum Teil nichtpropulsive Kontraktionswellen oder eine komplette Amotilität des Ösophaguskörpers gekennzeichnet. Klinisch äußert sie sich vor allem in Dysphagie und Regurgitationen. Eine medikamentöse Therapie ist bei geringgradiger Dysphagie möglich, bei ausgeprägter Dysphagie stellt die mechanische Dilatation eine initiale Therapieoption dar. Botulinumtoxin-Injektionen in den ösophagogastrischen Übergangsbereich schienen zunächst vielversprechend, es erwies sich aber, dass die Wirkung nur kurz anhält und wiederholte Applikationen erforderlich sind. Die chirurgische Behandlung, nämlich die Myotomie mit oder ohne Antirefluxplastik, wird vor allem nach erfolglosen Dilatationen durchgeführt, seit der Einführung minimal-invasiver chirurgischer Techniken aber zunehmend als primäre Therapie angewandt. Die vorliegende Arbeit gibt einen Überblick über die Entwicklung der konservativen und chirurgischen Behandlungsmethoden.

Schlüsselwörter

Achalasie Gastroösophagealer Sphinkter (GÖS) Dysphagie 

Treatment of achalasia

Summary

Achalasia is a condition of unknown etiology. It represents a motor disorder of the esophagus characterized by absent or incomplete relaxation of the lower esophageal sphincter upon swallowing and by nonpropulsive swallow-induced contraction waves or amotility of the esophageal body. Dysphagia and regurgitation of ingesta are the most frequent symptoms. Medical treatment, i.e. by calcium-channel blockers and nitric oxide donors, may be tried in patients with mild dysphagia or in elderly patients but rarely yields adequate symptom relief. Mechanical dilatation of the achalasic sphincter may be performed as an initial treatment option. Intrasphincteric injections of botulinum toxin seemed to be a promising alternative, but it has become obvious that, in most cases, repeated applications of the toxin are required to maintain patients symptom-free. Myotomy of the achalasic sphincter with or without fundoplication to prevent gastroesophageal reflux, is employed mainly in patients in whom dilatations have failed, but since the introduction of minimally invasive surgery, myotomy has become the primary treatment at many centers. This article aims to provide an overview of the development of the conservative and surgical treatment of achalasia.

Key words

Achalasia lower esophageal sphincter (LES) dysphagia 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Willis T (1674) Pharmaceutice rationalis sive diatribe de medicamentorum operationibus in corpore humano. Hagae-Comitis, London, p 36Google Scholar
  2. 2.
    von Mikulicz J (1882) Ueber Oesophagoskopie und Gastroskopie. Mittheilungen des Vereines der Aerzte in Nieder-Oesterreich 8: 41Google Scholar
  3. 3.
    Tyson J, Martin E, Evans JSJ (1904) Diffuse dilatation of the esophagus due to cardiospasm. NY Med J 80: 731Google Scholar
  4. 4.
    Jackson C (1922) The diaphragmatic pinchcock in socalled cardiospasm. Laryngoscope 32: 139Google Scholar
  5. 5.
    Mosher HP (1931) Fibrosis of the terminal portion of the esophagus: cardiospasm. Proc Int Assemb Inter St Postgrad MA, North Am 6: 95Google Scholar
  6. 6.
    Hertz AF (1914) Achalasia of the cardia. Q J Med 8: 300–308Google Scholar
  7. 7.
    Mayberry JF (2001) Epidemiology and demographics of achalasia. Gastrointest Endosc Clin N Am 11: 235–248PubMedGoogle Scholar
  8. 8.
    Raymond L, Lach B, Shamji FM (1999) Inflammatory aetiology of primary oesophageal achalasia: an immuno-histochemical and ultrastructural study of Auerbach’s plexus. Histopathology 35: 445–453PubMedCrossRefGoogle Scholar
  9. 9.
    Qualman SJ, Haupt HM, Yang P, Hamilton SR (1984) Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson’s disease. Gastroenterology 87: 848–856PubMedGoogle Scholar
  10. 10.
    Verne GN, Hahn AB, Pineau BC, Hoffman BJ, Wojciechowski BW, Wu WC (1999) Association of HLA-DR and-DQ alleles with idiopathic achalasia. Gastroenterology 117: 26–31PubMedCrossRefGoogle Scholar
  11. 11.
    Robertson CS, Martin BA, Atkinson M (1993) Varicellazoster virus DNA in the oesophageal myenteric plexus in achalasia. Gut 34: 299–302PubMedCrossRefGoogle Scholar
  12. 12.
    Verne GN, Sallustio JE, Eaker EY (1997) Anti-myenteric neuronal antibodies in patients with achalasia. A prospective study. Dig Dis Sci 42: 307–313PubMedCrossRefGoogle Scholar
  13. 13.
    Mearin F, Mourelle M, Guarner F, Salas A, Riveros-Moreno V, Moncada S, Malagelada JR (1993) Patients with achalasia lack nitric oxide synthase in the gastrooesophageal junction. Eur J Clin Invest 23: 724–728PubMedCrossRefGoogle Scholar
  14. 14.
    Takahashi T (2003) Pathophysiological significance of neuronal nitric oxide synthase in the gastrointestinal tract. J Gastroenterol 38: 421–430PubMedCrossRefGoogle Scholar
  15. 15.
    de Oliveira RB, Troncon LE, Dantas RO, Menghelli UG (1998) Gastrointestinal manifestations of Chagas’ disease. Am J Gastroenterol 93: 884–889PubMedCrossRefGoogle Scholar
  16. 16.
    Howard P, Maher L, Pryde A, Cameron E, Heading R (1992) Five year prospective study of the incidence, clinical features, and diagnosis of achalasia in Edinburgh. Gut 33: 1011–1015.PubMedCrossRefGoogle Scholar
  17. 17.
    Crookes PF, Corkill S, DeMeester TR (1997) Gastroesophageal reflux in achalasia. When is reflux really reflux? Dig Dis Sci 42: 1354–1361PubMedCrossRefGoogle Scholar
  18. 18.
    Brucher BL, Stein HJ, Bartels H, Feussner H, Siewert JR (2001) Achalasia and esophageal cancer: incidence, prevalence, and prognosis. World J Surg 25: 745–749PubMedCrossRefGoogle Scholar
  19. 19.
    Schima W, Stacher G, Pokieser P, Uranitsch K, Nekahm D, Schober E, Moser G, Tscholakoff D (1992) Esophageal motor disorders: videofluoroscopic and manometric evaluation — prospective study in 88 symptomatic patients. Radiology 185: 487–491PubMedGoogle Scholar
  20. 20.
    Feussner H, Kauer W, Siewert JR (1993) The place of esophageal manometry in the diagnosis of dysphagia. Dysphagia 8: 98–104PubMedCrossRefGoogle Scholar
  21. 21.
    Stacher G, Bergmann H (1992) Seintigraphic quantitation of gastrointestinal motor activity and transport: oesophagus and stomach. Eur J Nucl Med 19: 815–823PubMedCrossRefGoogle Scholar
  22. 22.
    Traube M, Dubovik S, Lange RC, McCallum RW (1989) The role of nifedipine therapy in achalasia: results of a randomized, double-blind, placebo-controlled study. Am J Gastroenterol 84: 1259–1262PubMedGoogle Scholar
  23. 23.
    Wong RK, Maydonovitch C, Garcia JE, Johnson LF, Castell DO (1987) The effect of terbutaline sulfate, nitroglycerin, and aminophylline on lower esophageal sphincter pressure and radionuclide esophageal emptying in patients with achalasia. J Clin Gastroenterol 9: 386–389PubMedCrossRefGoogle Scholar
  24. 24.
    DiMarino AJ, Jr., Cohen S (1982) Effect of an oral beta2-adrenergic agonist on lower esophageal sphincter pressure in normals and in patients with achalasia. Dig Dis Sci 27: 1063–1066PubMedCrossRefGoogle Scholar
  25. 25.
    Marzio L, Grossi L, DeLaurentiis MF, Cennamo L, Lapenna D, Cuccurullo F (1994) Effect of cimetro pium bromide on esophageal motility and transit in patients affected by primary achalasia. Dig Dis Sci 39: 1389–1394PubMedCrossRefGoogle Scholar
  26. 26.
    Blasi J, Chapman ER, Link E, Binz T, Yamasaki S, De Camilli P, Sudhof TC, Niemann H, Jahn R (1993) Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365: 160–163PubMedCrossRefGoogle Scholar
  27. 27.
    Schnider P, Voller B, Moraru K, Auff E (1999) Botulinum toxin therapy: from dreaded biological toxin to standard pharmaceutical. Wien Klin Wochenschr 111: 825–829PubMedGoogle Scholar
  28. 28.
    Pamphlett R (1989) Early terminal and nodal sprouting of motor axons after botulinum toxin. J Neurol Sci 92: 181–192PubMedCrossRefGoogle Scholar
  29. 29.
    McJunkin B, McMillan WO Jr, Duncan HE Jr, Harman KM, White JJ Jr, McJunkin JE (1991) Assessment of dilation methods in achalasia: large diameter mercury bougienage followed by pneumatic dilation as needed. Gastrointest Endosc 37: 18–21PubMedCrossRefGoogle Scholar
  30. 30.
    Mandelstam P, Block C, Newell L, Dillon M (1982) The role of bougienage in the management of achalasia — the need for reappraisal. Gastrointest Endosc 28: 169–172PubMedCrossRefGoogle Scholar
  31. 31.
    Starck H (1924) Die Behandlung der spasmogenen Speiseröhrenerweiterung. Munch Med Wochenschr 71: 334–336Google Scholar
  32. 32.
    Earlam R, Cunha-Melo JR (1981) Benign oesophageal strictures: historical and technical aspects of dilatation. Br J Surg 68: 829–836PubMedCrossRefGoogle Scholar
  33. 33.
    Mearin F, Armengol JR, Chicharro L, Papo M, Balboa A, Malagelada JR (1994) Forceful dilatation under endoscopic control in the treatment of achalasia: a randomised trial of pneumatic versus metallic dilator. Gut 35: 1360–1362PubMedCrossRefGoogle Scholar
  34. 34.
    Vakil N, Kadakia S, Eckardt VF (2003) Pneumatic dilation in achalasia. Endoscopy 35: 526–530PubMedCrossRefGoogle Scholar
  35. 35.
    Van Goidsenhoven GE, Vantrappen G, Verbeke S, Vandenbroucke J (1963) Treatment of achalasia of the cardia with pneumatic dilations. Gastroenterology 45: 326–334Google Scholar
  36. 36.
    Nanson EM (1966) Treatment of achalasia of the cardia. Gastroenterology 51: 236–241PubMedGoogle Scholar
  37. 37.
    Heller E (1914) Extramuköse Cardiaplastik beim chronischen Cardiospasmus mit Dilatation des Oesophagus. Mitteilungen a d Grenzgebieten d Medizin u Chirurgie 27: 141–149Google Scholar
  38. 38.
    Ellis FH Jr (1993) Oesophagomyotomy for achalasia: a 22-year experience. Br J Surg 80: 882–885PubMedCrossRefGoogle Scholar
  39. 39.
    Patti MG, Pellegrini CA, Horgan S, Arcerito M, Omelanczuk P, Tamburini A, Diener U, Eubanks TR, Way LW (1999) Minimally invasive surgery for achalasia: an 8-year experience with 168 patients. Ann Surg 230: 587–593; discussion 593–594PubMedCrossRefGoogle Scholar
  40. 40.
    Kumar V, Shimi SM, Cuschieri A (1998) Does laparoscopic cardiomyotomy require an antireflux procedure? Endoscopy 30: 8–11PubMedCrossRefGoogle Scholar
  41. 41.
    Richards WO, Sharp KW, Holzman MD (2001) An antireflux procedure should not routinely be added to a Heller myotomy. J Gastrointest Surg 5: 13–16PubMedCrossRefGoogle Scholar
  42. 42.
    Maher JW, Conklin J, Heitshusen DS (2001) Thoracoscopic esophagomyotomy for achalasia: preoperative patterns of acid reflux and long-term follow-up. Surgery 130: 570–576: discussion 576–577PubMedCrossRefGoogle Scholar
  43. 43.
    Ellis FH (1991) Esophagomyotomy by the thoracic approach for esophageal achalasia. Hepatogastroenterology 38: 498–501PubMedGoogle Scholar
  44. 44.
    Cade R (2000) Heller’s myotomy: thoracoscopic or laparoscopic? Dis Esophagus 13: 279–281PubMedCrossRefGoogle Scholar
  45. 45.
    Ali A, Pellegrini CA (2001) Laparoscopic myotomy: technique and efficacy in treating achalasia. Gastrointest Endosc Clin N Am 11: 347–358, viiPubMedGoogle Scholar
  46. 46.
    Stewart KC, Finley RJ, Clifton JC, Graham AJ, Storseth C, Inculet R (1999) Thoracoscopic versus laparoscopic modified Heller myotomy for achalasia: efficacy and safety in 87 patients. J Am Coll Surg 189: 164–169; discussion 169–170PubMedCrossRefGoogle Scholar
  47. 47.
    Triadafilopoulos G, Aaronson M, Sackel S, Burakoff R (1991) Medical treatment of esophageal achalasia. Doubleblind crossover study with oral nifedipine, verapamil, and placebo, Dig Dis Sci 36: 260–267PubMedCrossRefGoogle Scholar
  48. 48.
    Coccia G, Bortolotti M, Michetti P, Dodero M (1991) Prospective clinical and manometric study comparing pneumatic dilatation and sublingual nifedipine in the treatment of oesophageal achalasia. Gut 32: 604–606PubMedCrossRefGoogle Scholar
  49. 49.
    Bortolotti M, Labo G (1981) Clinical and manometric effects of nifedipine in patients with esophageal achalasia. Gastroenterology 80: 39–44PubMedGoogle Scholar
  50. 50.
    Gelfond M, Rozen P, Gilat T (1982) Isosorbide dinitrate and nifedipine treatment of achalasia: a clinical, manometric and radionuclide evaluation. Gastroenterology 83: 963–969PubMedGoogle Scholar
  51. 51.
    Bortolotti M, Mari C, Lopilato C, Porrazzo G, Miglioli M (2000) Effects of sildenafil on esophageal motility of patients with idiopathic achalasia. Gastroenterology 118: 253–257PubMedCrossRefGoogle Scholar
  52. 52.
    Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA (1998) Oral sildenafil in the treatment of erectile dysfunction, Sildenafil Study Group. N Engl J Med 338: 1397–1404PubMedCrossRefGoogle Scholar
  53. 53.
    Pasricha PJ, Rai R, Ravich WJ, Hendrix TR, Kalloo AN (1996) Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology 110: 1410–1415PubMedCrossRefGoogle Scholar
  54. 54.
    Mikaeli J, Fazel A, Montazeri G, Yaghoobi M, Malekzadeh R (2001) Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia. Aliment Pharmacol Ther 15: 1389–1396PubMedCrossRefGoogle Scholar
  55. 55.
    Allescher HD, Storr M, Seige M, Gonzales-Donoso R, Ott R, Born P, Frimberger E, Weigert N, Stier A, Kurjak M, Rosch T, Classen M (2001) Treatment of achalasia: botulinum toxin injection vs. pneumatic balloon dilation. A prospective study with long-term follow-Up. Endoscopy 33: 1007–1017PubMedCrossRefGoogle Scholar
  56. 56.
    Cuilliere C, Ducrotte P, Zerbib F, Metman EH, de Looze D, Guillemot F, Hudziak H, Lamouliatte H, Grimaud JC, Ropert A, Dapoigny M, Bost R, Lemann M, Bigard MA, Denis P, Auget JL, Galmiche JP, Bruley des Varannes S (1997) Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin. Gut 41: 87–92PubMedGoogle Scholar
  57. 57.
    Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN (1995) Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 332: 774–778PubMedCrossRefGoogle Scholar
  58. 58.
    Eaker EY, Gordon JM, Vogel SB (1997) Untoward effects of esophageal botulinum tox in injection in the treatment of achalasia. Dig Dis Sci 42: 724–727PubMedCrossRefGoogle Scholar
  59. 59.
    Pratschner T, Schiessel R, Stacher M, Feil W, Schemper M (1996) Dilatationsbehandlung der Achalasie als Initialtherapie. Ergebnisse einer prospektiven Studie. Wien Klin Wochenschr 108: 191–195PubMedGoogle Scholar
  60. 60.
    Vaezi MF, Richter JE (1998) Current therapies for achalasia: comparison and efficacy. J Clin Gastroenterol 27: 21–35PubMedCrossRefGoogle Scholar
  61. 61.
    Sanderson DR, Ellis FH Jr, Olsen AM (1970) Achalasia of the esophagus: results of therapy by dilation, 1950–1967. Chest 58: 116–121PubMedCrossRefGoogle Scholar
  62. 62.
    Eckardt VF, Aignherr C, Bernhard G (1992) Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology 103: 1732–1738PubMedGoogle Scholar
  63. 63.
    Metman EH, Lagasse JP, d’Alteroche L, Picon L, Scotto B, Barbieux JP (1990) Risk factors for immediate complications after progressive pneumatic dilation for achalasia. Am J Gastroenterol 94: 1179–1185CrossRefGoogle Scholar
  64. 64.
    Lishman AH, Dellipiani AW (1982) Management of achalasia of the cardia by forced pneumatic dilatation. Gut 23: 541–544PubMedCrossRefGoogle Scholar
  65. 65.
    Cosentini E, Berlakovich G, Zacherl J, Stacher-Janotta G, Merio R, Wenzl E, Bergmann H, Stacher G (1997) Achalasia. Results of myotomy and antireflux operation after failed dilatations. Arch Surg 132: 143–147PubMedGoogle Scholar
  66. 66.
    Fellows IW, Ogilvie AL, Atkinson M (1983) Pneumatic dilatation in achalasia. Gut 24: 1020–1023PubMedCrossRefGoogle Scholar
  67. 67.
    Vantrappen G, Janssens J (1983) To dilate or to operate? That is the question. Gut 24: 1013–1019PubMedCrossRefGoogle Scholar
  68. 68.
    Patti MG, Feo CV, Arcerito M, De Pinto M, Tamburini A, Diener U, Gantert W, Way LW (1999) Effects of previous treatment on results of laparoscopic Heller myotomy for achalasia. Dig Dis Sci 44: 2270–2276PubMedCrossRefGoogle Scholar
  69. 69.
    Bonavina L, Nosadini A, Bardini R, Baessato M, Peracchia A (1992) Primary treatment of esophageal achalasia. Longterm results of myotomy and Dor fundoplication. Arch Surg 127: 222–226: discussion 227PubMedGoogle Scholar
  70. 70.
    Perretta S, Fisichella PM, Galvani C, Gorodner MV, Way LW, Patti MG (2003) Achalasia and chest pain: effect of laparoscopic Heller myotomy. J Gastrointest Surg 7: 595–598PubMedCrossRefGoogle Scholar
  71. 71.
    Wills VL, Hunt DR (2001) Functional outcome after Heller myotomy and fundoplication for achalasia. J Gastrointest Surg 5: 408–413PubMedCrossRefGoogle Scholar
  72. 72.
    Csendes A, Braghetto I, Henriquez A, Cortes C (1989) Late results of a prospective randomised study comparing forceful dilatation and oesophagomyotomy in patients with achalasia. Gut 30: 299–304PubMedCrossRefGoogle Scholar
  73. 73.
    Anselmino M, Perdikis G, Hinder RA, Polishuk PV, Wilson P, Terry JD, Lanspa SJ (1997) Heller myotomy is superior to dilatation for the treatment of early achalasia. Arch Surg 132: 233–240PubMedGoogle Scholar
  74. 74.
    Okike N, Payne WS, Neufeld DM, Bernatz PE, Pairolero PC, Sanderson DR (1979) Esophagomyotomy versus forceful dilation for achalasia of the esophagus: results in 899 patients. Ann Thorac Surg 28: 119–125PubMedGoogle Scholar
  75. 75.
    Ancona E, Anselmino M, Zaninotto G, Costantini M, Rossi M, Bonavina L, Boccu C, Buin F, Peracchia A (1995) Esophageal achalasia: laparoscopic versus conventional open Heller-Dor operation. Am J Surg 170: 265–270PubMedCrossRefGoogle Scholar
  76. 76.
    Bloomston M, Serafini F, Rosemurgy AS (2001) Videoscopic Heller myotomy as first-line therapy for severe achalasia. Am Surg 67: 1105–1109PubMedGoogle Scholar
  77. 77.
    Patti MG, Fisichella PM, Perretta S, Galvani C, Gorodner MV, Robinson T, Way LW (2003) Impact of minimally invasive surgery on the treatment of esophageal achalasia: a decade of change. J Am Coll Surg 196: 698–703; discussion 703–705PubMedCrossRefGoogle Scholar
  78. 78.
    Patti MG, Molena D, Fisichella PM, Whang K, Yamada H, Perretta S, Way LW (2001) Laparoscopic Heller myotomy and Dor fundoplication for achalasia: analysis of successes and failures. Arch Surg 136: 870–877PubMedCrossRefGoogle Scholar
  79. 79.
    Andreollo NA, Earlam RJ (1987) Heller’s myotomy for achalasia: is an added anti-reflux procedure necessary? Br J Surg 74: 765–769PubMedCrossRefGoogle Scholar
  80. 80.
    Reynolds JC, Parkman HP (1989) Achalasia. Gastroenterol Clin North Am 18: 223–255PubMedGoogle Scholar
  81. 81.
    Peters JH, DeMeester TR (1995) Surgery for esophageal motor disorders. In: Castell DO (ed) The esophagus, 2nd edn. Little, Brown, Boston, pp 395–434Google Scholar
  82. 82.
    Lyass S, Thoman D, Steiner JP, Phillips E (2003) Current status of an antireflux procedure in laparoscopic Heller myotomy. Surg Endosc 17: 554–558PubMedCrossRefGoogle Scholar
  83. 83.
    Gadenstatter M, Klingler A, Klocker H, Wetscher GJ (2000) Long-term results of laparoscopic partial posterior fundoplication in patients with esophageal reflux and disorders of esophageal peristalsis. Wien Klin Wochenschr 112: 70–74PubMedGoogle Scholar
  84. 84.
    Gadenstatter M, Klocker J, Weiss H, Wetscher GJ (2000) Prokinetic medication after surgical therapy of reflux patients with disorders of esophageal peristalsis: a randomized clinical study. Wien Klin Wochenschr 112: 917–921PubMedGoogle Scholar
  85. 85.
    Hunter JG, Richardson WS (1997) Surgical management of achalasia. Surg Clin North Am 77: 993–1015PubMedCrossRefGoogle Scholar
  86. 86.
    Orringer MB, Stirling MC (1989) Esophageal resection for achalasia: indications and results. Ann Thorac Surg 47: 340–345PubMedCrossRefGoogle Scholar
  87. 87.
    Pinotti HW, Cecconello I, da Rocha JM, Zilberstein B (1991) Resection for achalasia of the esophagus. Hepatogastroenterology 38: 470–473PubMedGoogle Scholar
  88. 88.
    Peters JH, Kauer WK, Crookes PF, Ireland AP, Bremner CG, DeMeester TR (1995) Esophageal resection with colon interposition for end-stage achalasia. Arch Surg 130: 632–636: discussion 636–637PubMedGoogle Scholar
  89. 89.
    Kneist W, Sultanov F, Eckardt VF, Junginger T (2002) Osophagusresektion zur Behandlung der Achalasie. Vier Fallberichte und Übersicht über die Literatur. Chirurg 73: 223–229PubMedCrossRefGoogle Scholar
  90. 90.
    Seelig MH, De Vault KR, Seelig SK, Klinger PJ, Branton SA, Floch NR, Bammer T, Hinder RA (1999) Treatment of achalasia: recent advances in surgery. J Clin Gastroenterol 28: 202–207PubMedCrossRefGoogle Scholar
  91. 91.
    Cosentini E, Riegler M, Koperek O, Wenzl E (2004) Transgastric stapled esophagofundostomy (TSE) and partial fundoplication — a technical illustration of a new concept for surgical treatment of achalasia. Eur Surg 36: 89–94CrossRefGoogle Scholar
  92. 92.
    Bremner CG (2004) Invited commentary to: transgastric stapled esophagofundostomy (TSE) and partial fundoplication — a technical illustration of a new concept for surgical treatment of achalasia. Eur Surg 36: 95–96CrossRefGoogle Scholar
  93. 93.
    Ellis FH Jr, Crozier RE, Gibb SP (1986) Reoperative achalasia surgery. J Thorac Cardiovasc Surg 92: 859–865PubMedGoogle Scholar
  94. 94.
    Ellis FH Jr, Gibb SP (1975) Reoperation after esophagomy otomy for achalasia of the esophagus. Am J Surg 129: 407–412PubMedCrossRefGoogle Scholar
  95. 95.
    Vaezi MF, Richter JE (1999) Diagnosis and management of achalasia. American College of Gastroenterology Practice Parameter Committee. Am J Gastroenterol 94: 3406–3412PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2004

Authors and Affiliations

  • Enrico P. Cosentini
    • 1
  • Etienne Wenzl
    • 1
  • Raimund Jakesz
    • 1
  1. 1.Klinische Abteilung für AllgemeinchirurgieUniversitätsklinik für ChirurgieWienÖsterreich

Personalised recommendations